Loading…

Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors

The advantages gained by a combined treatment of different chemical protectors on short-term lethality of X-irradiated adult male mice have been studied. The following compounds were given alone or in a mixture of two or three compounds: 16,16-dimethyl PGE2 ( PGE2), cysteine (Cys), glucan, glutathio...

Full description

Saved in:
Bibliographic Details
Published in:Radiation research 1993-09, Vol.135 (3), p.332-337
Main Authors: Maisin, J. R., Albert, C., Henry, A.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c334t-d218838aeb96ac40c581aa7b54c9227be8817059973479431768cdc02e33d71b3
cites
container_end_page 337
container_issue 3
container_start_page 332
container_title Radiation research
container_volume 135
creator Maisin, J. R.
Albert, C.
Henry, A.
description The advantages gained by a combined treatment of different chemical protectors on short-term lethality of X-irradiated adult male mice have been studied. The following compounds were given alone or in a mixture of two or three compounds: 16,16-dimethyl PGE2 ( PGE2), cysteine (Cys), glucan, glutathione (GSH), 5-hydroxytryptamine (5-HT), mercaptoproprionylglycine (MPG), or WR-2721. The survival of mice treated before X irradiation with the optimal dose of each radioprotector given separately shows that WR-2721 and 5-HT yield the best protection with dose reduction factors (DRFs) of 2.2 and 1.7, respectively. Cysteine, glucan, PGE2, MPG, and GSH, with DRFs of 1.4, 1.4, 1.2, 1.1, and 1.1, respectively, are less efficient radioprotectors. When PGE2 was combined with a low dose of WR-2721 (200 mg/kg), the protection increased in a synergistic way. The increase in protection offered by a combination of PGE2 with Cys, glucan, GSH, or 5-HT is less marked and the effect obtained is only additive. A synergistic action is also obtained with a combination of WR-2721 (200 mg/kg) and 5-HT (8 mg/kg) (DRF 2.7).
doi_str_mv 10.2307/3578872
format article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2307_3578872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3578872</jstor_id><sourcerecordid>3578872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-d218838aeb96ac40c581aa7b54c9227be8817059973479431768cdc02e33d71b3</originalsourceid><addsrcrecordid>eNp1kN9KwzAUxoMoc07xCYRcCF5VkyZd0ss5dAqTyZzXJU1PbUbXjCRT9gi-tXUrwxuvzr8f3-H7ELqk5DZmRNyxREgp4iPUpymTUcIJP0Z9QhiLRCLFKTrzfknamQ7THupJlgoeyz76nkOx0cHYBtsSv1XWhWgBboXnqjBqt59CqFRtwhbnW3xvbG0_jFY1noNf28YDfrGFKQ04jyfmExo8qm0D2Dps2t57qzuhLxMqPAsVODyuYLUTeXU2gA7W-XN0Uqraw0VXB-j98WExfoqms8nzeDSNNGM8REVMpWRSQZ4OleZEJ5IqJfKE6zSORQ5SUkGSNBWMi5QzKoZSF5rEwFghaM4G6Gavq5313kGZrZ1ZKbfNKMl-s8y6LFvyak-uN_kKigPXhdfer7u78q2X0qlGG3_AOBWJoH-wpW99_vvtB9UwhyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors</title><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Maisin, J. R. ; Albert, C. ; Henry, A.</creator><creatorcontrib>Maisin, J. R. ; Albert, C. ; Henry, A.</creatorcontrib><description>The advantages gained by a combined treatment of different chemical protectors on short-term lethality of X-irradiated adult male mice have been studied. The following compounds were given alone or in a mixture of two or three compounds: 16,16-dimethyl PGE2 ( PGE2), cysteine (Cys), glucan, glutathione (GSH), 5-hydroxytryptamine (5-HT), mercaptoproprionylglycine (MPG), or WR-2721. The survival of mice treated before X irradiation with the optimal dose of each radioprotector given separately shows that WR-2721 and 5-HT yield the best protection with dose reduction factors (DRFs) of 2.2 and 1.7, respectively. Cysteine, glucan, PGE2, MPG, and GSH, with DRFs of 1.4, 1.4, 1.2, 1.1, and 1.1, respectively, are less efficient radioprotectors. When PGE2 was combined with a low dose of WR-2721 (200 mg/kg), the protection increased in a synergistic way. The increase in protection offered by a combination of PGE2 with Cys, glucan, GSH, or 5-HT is less marked and the effect obtained is only additive. A synergistic action is also obtained with a combination of WR-2721 (200 mg/kg) and 5-HT (8 mg/kg) (DRF 2.7).</description><identifier>ISSN: 0033-7587</identifier><identifier>EISSN: 1938-5404</identifier><identifier>DOI: 10.2307/3578872</identifier><identifier>PMID: 8397428</identifier><identifier>CODEN: RAREAE</identifier><language>eng</language><publisher>Oak Brook, Il: Academic Press, Inc</publisher><subject>16,16-Dimethylprostaglandin E2 - therapeutic use ; Amifostine - therapeutic use ; Animals ; Biological and medical sciences ; Biological effects of radiation ; Cysteine - therapeutic use ; Dosage ; Drug Therapy, Combination ; Endotoxins ; Fundamental and applied biological sciences. Psychology ; Glucans ; Glucans - therapeutic use ; Immunologic Factors - therapeutic use ; Irradiation ; Male ; Mice ; Mice, Inbred Strains ; Mortality ; Protectors ; Radiation dosage ; Radiation Injuries, Experimental - mortality ; Radiation Injuries, Experimental - prevention &amp; control ; Radioprotection ; Serotonin - therapeutic use ; Serotonin receptors ; Solar X rays ; Tissues, organs and organisms biophysics</subject><ispartof>Radiation research, 1993-09, Vol.135 (3), p.332-337</ispartof><rights>Copyright 1993 Academic Press, Inc.</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-d218838aeb96ac40c581aa7b54c9227be8817059973479431768cdc02e33d71b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3578872$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3578872$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27915,27916,58229,58462</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4175718$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8397428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maisin, J. R.</creatorcontrib><creatorcontrib>Albert, C.</creatorcontrib><creatorcontrib>Henry, A.</creatorcontrib><title>Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors</title><title>Radiation research</title><addtitle>Radiat Res</addtitle><description>The advantages gained by a combined treatment of different chemical protectors on short-term lethality of X-irradiated adult male mice have been studied. The following compounds were given alone or in a mixture of two or three compounds: 16,16-dimethyl PGE2 ( PGE2), cysteine (Cys), glucan, glutathione (GSH), 5-hydroxytryptamine (5-HT), mercaptoproprionylglycine (MPG), or WR-2721. The survival of mice treated before X irradiation with the optimal dose of each radioprotector given separately shows that WR-2721 and 5-HT yield the best protection with dose reduction factors (DRFs) of 2.2 and 1.7, respectively. Cysteine, glucan, PGE2, MPG, and GSH, with DRFs of 1.4, 1.4, 1.2, 1.1, and 1.1, respectively, are less efficient radioprotectors. When PGE2 was combined with a low dose of WR-2721 (200 mg/kg), the protection increased in a synergistic way. The increase in protection offered by a combination of PGE2 with Cys, glucan, GSH, or 5-HT is less marked and the effect obtained is only additive. A synergistic action is also obtained with a combination of WR-2721 (200 mg/kg) and 5-HT (8 mg/kg) (DRF 2.7).</description><subject>16,16-Dimethylprostaglandin E2 - therapeutic use</subject><subject>Amifostine - therapeutic use</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biological effects of radiation</subject><subject>Cysteine - therapeutic use</subject><subject>Dosage</subject><subject>Drug Therapy, Combination</subject><subject>Endotoxins</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glucans</subject><subject>Glucans - therapeutic use</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Irradiation</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Mortality</subject><subject>Protectors</subject><subject>Radiation dosage</subject><subject>Radiation Injuries, Experimental - mortality</subject><subject>Radiation Injuries, Experimental - prevention &amp; control</subject><subject>Radioprotection</subject><subject>Serotonin - therapeutic use</subject><subject>Serotonin receptors</subject><subject>Solar X rays</subject><subject>Tissues, organs and organisms biophysics</subject><issn>0033-7587</issn><issn>1938-5404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNp1kN9KwzAUxoMoc07xCYRcCF5VkyZd0ss5dAqTyZzXJU1PbUbXjCRT9gi-tXUrwxuvzr8f3-H7ELqk5DZmRNyxREgp4iPUpymTUcIJP0Z9QhiLRCLFKTrzfknamQ7THupJlgoeyz76nkOx0cHYBtsSv1XWhWgBboXnqjBqt59CqFRtwhbnW3xvbG0_jFY1noNf28YDfrGFKQ04jyfmExo8qm0D2Dps2t57qzuhLxMqPAsVODyuYLUTeXU2gA7W-XN0Uqraw0VXB-j98WExfoqms8nzeDSNNGM8REVMpWRSQZ4OleZEJ5IqJfKE6zSORQ5SUkGSNBWMi5QzKoZSF5rEwFghaM4G6Gavq5313kGZrZ1ZKbfNKMl-s8y6LFvyak-uN_kKigPXhdfer7u78q2X0qlGG3_AOBWJoH-wpW99_vvtB9UwhyI</recordid><startdate>19930901</startdate><enddate>19930901</enddate><creator>Maisin, J. R.</creator><creator>Albert, C.</creator><creator>Henry, A.</creator><general>Academic Press, Inc</general><general>Radiation Research Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19930901</creationdate><title>Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors</title><author>Maisin, J. R. ; Albert, C. ; Henry, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-d218838aeb96ac40c581aa7b54c9227be8817059973479431768cdc02e33d71b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>16,16-Dimethylprostaglandin E2 - therapeutic use</topic><topic>Amifostine - therapeutic use</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biological effects of radiation</topic><topic>Cysteine - therapeutic use</topic><topic>Dosage</topic><topic>Drug Therapy, Combination</topic><topic>Endotoxins</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glucans</topic><topic>Glucans - therapeutic use</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Irradiation</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Mortality</topic><topic>Protectors</topic><topic>Radiation dosage</topic><topic>Radiation Injuries, Experimental - mortality</topic><topic>Radiation Injuries, Experimental - prevention &amp; control</topic><topic>Radioprotection</topic><topic>Serotonin - therapeutic use</topic><topic>Serotonin receptors</topic><topic>Solar X rays</topic><topic>Tissues, organs and organisms biophysics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maisin, J. R.</creatorcontrib><creatorcontrib>Albert, C.</creatorcontrib><creatorcontrib>Henry, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Radiation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maisin, J. R.</au><au>Albert, C.</au><au>Henry, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors</atitle><jtitle>Radiation research</jtitle><addtitle>Radiat Res</addtitle><date>1993-09-01</date><risdate>1993</risdate><volume>135</volume><issue>3</issue><spage>332</spage><epage>337</epage><pages>332-337</pages><issn>0033-7587</issn><eissn>1938-5404</eissn><coden>RAREAE</coden><abstract>The advantages gained by a combined treatment of different chemical protectors on short-term lethality of X-irradiated adult male mice have been studied. The following compounds were given alone or in a mixture of two or three compounds: 16,16-dimethyl PGE2 ( PGE2), cysteine (Cys), glucan, glutathione (GSH), 5-hydroxytryptamine (5-HT), mercaptoproprionylglycine (MPG), or WR-2721. The survival of mice treated before X irradiation with the optimal dose of each radioprotector given separately shows that WR-2721 and 5-HT yield the best protection with dose reduction factors (DRFs) of 2.2 and 1.7, respectively. Cysteine, glucan, PGE2, MPG, and GSH, with DRFs of 1.4, 1.4, 1.2, 1.1, and 1.1, respectively, are less efficient radioprotectors. When PGE2 was combined with a low dose of WR-2721 (200 mg/kg), the protection increased in a synergistic way. The increase in protection offered by a combination of PGE2 with Cys, glucan, GSH, or 5-HT is less marked and the effect obtained is only additive. A synergistic action is also obtained with a combination of WR-2721 (200 mg/kg) and 5-HT (8 mg/kg) (DRF 2.7).</abstract><cop>Oak Brook, Il</cop><pub>Academic Press, Inc</pub><pmid>8397428</pmid><doi>10.2307/3578872</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-7587
ispartof Radiation research, 1993-09, Vol.135 (3), p.332-337
issn 0033-7587
1938-5404
language eng
recordid cdi_crossref_primary_10_2307_3578872
source JSTOR Archival Journals and Primary Sources Collection
subjects 16,16-Dimethylprostaglandin E2 - therapeutic use
Amifostine - therapeutic use
Animals
Biological and medical sciences
Biological effects of radiation
Cysteine - therapeutic use
Dosage
Drug Therapy, Combination
Endotoxins
Fundamental and applied biological sciences. Psychology
Glucans
Glucans - therapeutic use
Immunologic Factors - therapeutic use
Irradiation
Male
Mice
Mice, Inbred Strains
Mortality
Protectors
Radiation dosage
Radiation Injuries, Experimental - mortality
Radiation Injuries, Experimental - prevention & control
Radioprotection
Serotonin - therapeutic use
Serotonin receptors
Solar X rays
Tissues, organs and organisms biophysics
title Reduction of Short-Term Radiation Lethality by Biological Response Modifiers Given Alone or in Association with Other Chemical Protectors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A20%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20of%20Short-Term%20Radiation%20Lethality%20by%20Biological%20Response%20Modifiers%20Given%20Alone%20or%20in%20Association%20with%20Other%20Chemical%20Protectors&rft.jtitle=Radiation%20research&rft.au=Maisin,%20J.%20R.&rft.date=1993-09-01&rft.volume=135&rft.issue=3&rft.spage=332&rft.epage=337&rft.pages=332-337&rft.issn=0033-7587&rft.eissn=1938-5404&rft.coden=RAREAE&rft_id=info:doi/10.2307/3578872&rft_dat=%3Cjstor_cross%3E3578872%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c334t-d218838aeb96ac40c581aa7b54c9227be8817059973479431768cdc02e33d71b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/8397428&rft_jstor_id=3578872&rfr_iscdi=true